These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 5785966
1. Chemotherapeutic activity of 5-fluorocytosine against a lethal Candida albicans infection in mice. Pittillo RF, Ray BJ. Appl Microbiol; 1969 May; 17(5):773-4. PubMed ID: 5785966 [Abstract] [Full Text] [Related]
2. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice. Rabinovich S, Shaw BD, Bryant T, Donta ST. J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179 [No Abstract] [Full Text] [Related]
3. Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice. Titsworth E, Grunberg E. Antimicrob Agents Chemother; 1973 Sep; 4(3):306-8. PubMed ID: 4586144 [Abstract] [Full Text] [Related]
4. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses. Fass RJ, Perkins RL. Ann Intern Med; 1971 Apr; 74(4):535-9. PubMed ID: 5551162 [No Abstract] [Full Text] [Related]
5. Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. Hoeprich PD, Ingraham JL, Kleker E, Winship MJ. J Infect Dis; 1974 Aug; 130(2):112-8. PubMed ID: 4842332 [No Abstract] [Full Text] [Related]
6. 5-Fluorocytosine in the treatment of experimental candidiasis in immunosuppressed mice. Linquist JA, Rabinovich S, Smith IM. Antimicrob Agents Chemother; 1973 Jul; 4(1):58-61. PubMed ID: 4598845 [Abstract] [Full Text] [Related]
7. Correlation between in vitro and in vivo activity of antifungal agents against Candida species. Anaissie EJ, Karyotakis NC, Hachem R, Dignani MC, Rex JH, Paetznick V. J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024 [Abstract] [Full Text] [Related]
8. Candida albicans arthritis treated with flucytosine. Lindström FD, Lindholm T. Ann Intern Med; 1973 Jul; 79(1):131. PubMed ID: 4578636 [No Abstract] [Full Text] [Related]
13. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice. Ju JY, Polhamus C, Marr KA, Holland SM, Bennett JE. Antimicrob Agents Chemother; 2002 May; 46(5):1240-5. PubMed ID: 11959551 [Abstract] [Full Text] [Related]
14. Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo. Cacciapuoti A, Gurnani M, Halpern J, Norris C, Patel R, Loebenberg D. Antimicrob Agents Chemother; 2005 Feb; 49(2):638-42. PubMed ID: 15673745 [Abstract] [Full Text] [Related]
15. Pulmonary candidiasis treated with 5-fluorocytosine. Kohlschütter A, Pelet B. Arch Dis Child; 1974 Feb; 49(2):154-6. PubMed ID: 4593821 [No Abstract] [Full Text] [Related]
16. Candida albicans septicaemia during first half of pregnancy successfully treated with 5-fluorocytosine. Schönebeck J, Segerbrand E. Br Med J; 1973 Nov 10; 4(5888):337-8. PubMed ID: 4202261 [No Abstract] [Full Text] [Related]
17. Systemic antifungal activity of pyrrolnitrin. Gordee RS, Matthews TR. Appl Microbiol; 1969 May 10; 17(5):690-4. PubMed ID: 5785951 [Abstract] [Full Text] [Related]
19. C. albicans resistance to 5-fluorocytosine. Logan RL, Goldberg MJ. Br Med J; 1972 Aug 26; 3(5825):531. PubMed ID: 4560727 [No Abstract] [Full Text] [Related]